Pieverse price prediction October 2026

PIEVERSERank #145AIUpdated 25 Oct 2026, 15:30 UTC · Reviewed by Rowan Hale

Our model expects Pieverse to trade between $0.740 and $1.38 by 22 November 2026, with a base case of $0.980 (-4.8%).

Price$1.03▲ 0.1% 24h
7 days-4.8%from $1.08
24h volume$3.12M1.1% of cap
Market cap$282.75MRank #145
All-time high$1.98-48.0% from ATH
Circulating274.75Mof 1B max
Market data by CoinGecko. Forecasts by the CoinPredict model.

AI verdict

model 1d-20261023-1104 · made 23 Oct 2026, 00:00 UTC
30-day directionNeutral
Confidence—
Risk score38 / 100 · Moderate
Volatility, liquidity, cap tier, drawdown
30-day base case$0.980 -4.8%
80% range$0.740 – $1.38
Expires22 Nov 2026

Price and 30-day forecast

21 Oct21 Oct22 OctToday22 Nov
PriceBase case50% and 80% ranges

Forecast by horizon

Low and high are the 10th and 90th percentiles
HorizonLowBaseHighChangeConfidenceExpires
24 hours$0.969$1.02$1.07-1.1%—24 Oct 2026
7 days$0.885$1.01$1.16-1.8%—30 Oct 2026
30 days$0.740$0.980$1.38-4.8%—22 Nov 2026
90 days$0.538$0.903$1.66-12.3%—21 Jan 2027
180 days$0.396$0.799$1.83-22.3%—21 Apr 2027

Long-term scenarios, 2026 to 2030

Scenarios, not forecasts

Built from Pieverse's past cycle drawdowns and the growth of its market-cap tier. Each row links to a month-by-month page.

Year-endBearBaseBullBase vs today
2026$0.517$0.972$1.83-5.5%2026 →
2027$0.154$0.757$3.72-26.4%2027 →
2028$0.0678$0.589$5.12-42.7%2028 →
2029$0.0338$0.459$6.24-55.4%2029 →
2030$0.0180$0.358$7.12-65.2%2030 →

Technicals

RSI (14, daily)28 · Oversold
MACDBearish cross, 25 days ago
50-day average$1.31 · price below
200-day average$0.888 · price above
Resistance 2$1.07
Resistance 1$1.04
Support 1$0.997
Support 2$0.898

How our Pieverse calls did

Full track record →
24-hour calls in range100%of 1 graded
Direction correct0%of 1 graded
Median miss2.5%base vs actual

Where do you think Pieverse goes this month?

Votes are unavailable right now.

Not financial advice.Forecasts are model estimates, not guarantees. Crypto is volatile — do your own research.Read the disclaimer